Establishment Labs (ESTA) vs iRadimed (IRMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Establishment Labs (ESTA) has outperformed iRadimed (IRMD) over the past year, gaining 53.7% versus a gain of 16.0%. Over five years, IRMD leads with a +138.5% price change compared with -19.9% for ESTA. Establishment Labs is the larger company by market cap ($1.84 billion vs $1.12 billion), about 1.6 times the size.
On valuation, iRadimed trades at a lower forward P/E (35.6x vs 1027.8x for Establishment Labs). iRadimed pays a dividend yielding 0.88%, while Establishment Labs does not currently pay one. iRadimed converts more of its revenue into profit, with a net margin of 26.8% versus -24.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ESTA | IRMD |
|---|---|---|
| Share price | $61.67 | $87.45 |
| Market cap | $1.84B | $1.12B |
| 1-day change | +1.75% | +1.83% |
| YTD return | -15.38% | -10.10% |
| 1-year return | +53.71% | +15.95% |
| 5-year return | -19.91% | +138.48% |
| P/E ratio (TTM) | — | 48.85 |
| Forward P/E | — | 35.65 |
| EPS (TTM) | $-1.30 | $1.79 |
| Dividend yield | 0.00% | 0.88% |
| Annual dividend | $0.00 | $0.77 |
| Revenue (latest FY) | $211.08M | $83.81M |
| Revenue growth (YoY) | +27.14% | +14.43% |
| Net income (latest FY) | $-51.06M | $22.48M |
| Gross margin | 69.32% | 76.75% |
| Operating margin | -18.48% | 31.20% |
| Net margin | -24.19% | 26.82% |
| 52-week high | $97.59 | $107.90 |
| 52-week low | $38.55 | $71.34 |
| Distance from 52-week high | -36.81% | -18.95% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +66.11% | +34.93% |
| Average volume | 427.57K | 125.52K |
| Shares outstanding | 29.80M | 12.79M |
| Employees | 1,004 | 166 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ESTA has outperformed IRMD by 37.8 percentage points over the past year.
- iRadimed is more profitable, keeping 26.8 cents of every revenue dollar as net income versus -24.2 cents for Establishment Labs.
- Establishment Labs grew revenue faster in its latest fiscal year (+27.14% vs +14.43%).
About Establishment Labs
ESTA stock →Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand.
Health Care · Industrial Specialties · 1,004 employees
About iRadimed
IRMD stock →IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device.
Health Care · Medical/Dental Instruments · 166 employees
ESTA vs IRMD FAQ
Which is bigger, Establishment Labs or iRadimed?
Establishment Labs (ESTA) is larger, with a market capitalization of $1.84B compared with $1.12B for iRadimed (IRMD).
Which stock has performed better over the past year, ESTA or IRMD?
ESTA returned +53.71% over the past 12 months, compared with +15.95% for IRMD (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Establishment Labs or iRadimed?
iRadimed pays a dividend yielding 0.88%, while Establishment Labs does not currently pay a regular dividend.
Are Establishment Labs and iRadimed in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for Establishment Labs and Medical/Dental Instruments for iRadimed.